Ardsley Advisory Partners’s Abeona Therapeutics ABEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-1,000
Closed -$26K 130
2020
Q3
$26K Sell
1,000
-1,000
-50% -$63K 0.01% 142
2020
Q2
$146K Buy
2,000
+400
+25% +$27.6K 0.03% 121
2020
Q1
$84K Buy
1,600
+400
+33% +$26.7K 0.03% 91
2019
Q4
$98K Hold
1,200
0.02% 141
2019
Q3
$68K Sell
1,200
-400
-25% -$30K 0.02% 128
2019
Q2
$190K Buy
1,600
+400
+33% +$67.1K 0.03% 132
2019
Q1
$221K Buy
1,200
+451
+60% +$80.6K 0.04% 115
2018
Q4
$134K Sell
749
-651
-47% -$142K 0.03% 93
2018
Q3
$448K Buy
1,400
+400
+40% +$142K 0.06% 110
2018
Q2
$400K Sell
1,000
-200
-17% -$87.4K 0.06% 121
2018
Q1
$428K Sell
1,200
-400
-25% -$149K 0.06% 107
2017
Q4
$634K Sell
1,600
-400
-20% -$165K 0.08% 87
2017
Q3
$853K Sell
2,000
-400
-17% -$107K 0.11% 76
2017
Q2
$383K Buy
2,400
+600
+33% +$81.9K 0.06% 106
2017
Q1
$224K Buy
1,800
+200
+13% +$25.8K 0.03% 131
2016
Q4
$194K Buy
1,600
+800
+100% +$125K 0.03% 117
2016
Q3
$120K Buy
+800
New +$78.2K 0.02% 148

Other funds holding ABEO

Ardsley Advisory Partners's ABEO Position: Q4 2020 in Review

Ardsley Advisory Partners sold out of Abeona Therapeutics (ABEO) in Q4 2020, closing a stake of 1,000 shares — an estimated $26K sold.

Ardsley Advisory Partners first reported a position in ABEO in Q3 2016 and held it in 17 quarters. The position peaked at $853K in Q3 2017. 73 funds tracked by Wall St. Rank hold ABEO as of Q4 2020.

  • Ardsley Advisory Partners reported no remaining Abeona Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Ardsley Advisory Partners sold 1,000 Abeona Therapeutics shares in Q4 2020, an estimated $26K.
  • Ardsley Advisory Partners first reported a position in Abeona Therapeutics in Q3 2016 and held it in 17 quarters.
  • Ardsley Advisory Partners's Abeona Therapeutics position peaked at $853K in Q3 2017.
  • 73 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q4 2020.

Based on Ardsley Advisory Partners's 13F filing for Q4 2020, filed 16 Feb 2021.